eISSN: None / ISSN: 1673-5269
Register
Login
Volume 32 Issue 1 (2025): None
Articles
Efficacy of Efgartigimod in the treatment of immune checkpoint inhibitor related myasthenia gravis tumor patients; 艾加莫德治疗免疫检查点抑制剂相关重症肌无力肿瘤患者效果研究
57-62
Construction of a prognostic column chart model for primary gastric cancer patients based on progranulin expression; 基于颗粒体蛋白前体表达的原发性胃癌患者预后列线图模型构建
46-56
Prediction model construction and external validation of the relationship between type 2 diabetes mellitus and non-recurrence survival in breast cancer; 2 型糖尿病与乳腺癌无复发生存关系的预测模型构建与外部验证
37-38
Mechanism study of miR-508-3p targeting SULT1C4 mediated malignant behavior in nasopharyngeal carcinoma; 犕犻犚.508.3狆靶向犛犝犔犜1犆4介导鼻咽癌恶性行为的机制研究
28-36
Colorectal cancer incidence and mortality in Shangdong Province in 2019 and trend analysis from 2015 to 2019; 山东省肿瘤登记地区2019年结直肠癌发病和死亡情况与2015-2019年变化趋势分析
18-27
Awareness of core knowledge about cancer prevention and control among residents in Zhejiang Province and its influencing factors in 2023; 2023年浙江省居民癌症防治核心知识知晓水平及其影响因素分析
10-17
Investigation and analysis of Cancer prevention and treatment core knowledge awareness and health literacy among the tumor Screening population in Tianjin; 天津市肿瘤筛查人群的癌症防治核心知识及健康素养调查分析
1-9

For any inquiries regarding the journal, publication process, or manuscript status, please contact the Editorial Office at support@cjcpt.org.

 

Authors are requested to submit their manuscripts and related documents via email at submission@cjcpt.org

 

Address: Jinan, Shandong Province, Ji Yan Road #440 - Location

 

Please contact us on WhatsApp: https://wa.me/447460013985 

Open Access Publication